Zeer Indivior / intent / indivior

Indivior

1001-5000 employees·Richmond, Virginia, United States·indivior.com

Observed, not inferred · updated weekly

Buying intent

26 tracked signals | Top 15 topics are below | Data and Engineering are carrying most of it.

21signals · 30 days
20topics tracked
16.67%attributed to a team

Attention by team

LinkedIn activity, by team

Where Indivior's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Pharmaceutical
Artificial Intelligence
Hiring
Sales Development
Career Development
Dreamforce
Data
Data to Pharmaceutical: no signal
Medium100% of team Data to Artificial Intelligence: Medium, 100% of this team's signals
Data to Hiring: no signal
Data to Sales Development: no signal
Data to Career Development: no signal
Data to Dreamforce: no signal
Engineering
Engineering to Pharmaceutical: no signal
Engineering to Artificial Intelligence: no signal
Medium100% of team Engineering to Hiring: Medium, 100% of this team's signals
Engineering to Sales Development: no signal
Engineering to Career Development: no signal
Engineering to Dreamforce: no signal
Others
High30% of team Others to Pharmaceutical: High, 30% of this team's signals
Medium10% of team Others to Artificial Intelligence: Medium, 10% of this team's signals
Medium10% of team Others to Hiring: Medium, 10% of this team's signals
High20% of team Others to Sales Development: High, 20% of this team's signals
High20% of team Others to Career Development: High, 20% of this team's signals
Medium10% of team Others to Dreamforce: Medium, 10% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Pharmaceutical
LinkedIn
High volume
97%
last
22d ago
Artificial Intelligence
LinkedIn
High volume
96%
last
12d ago
Hiring
LinkedIn
High volume
95%
last
25d ago
Sales Development
LinkedIn
High volume
98%
last
22d ago
Career Development
LinkedIn
High volume
89%
last
11d ago
Dreamforce
LinkedIn
Medium volume
92%
last
19d ago
Engineering team
LinkedIn
Medium volume
98%
last
12d ago
Opportunity
LinkedIn
Medium volume
92%
last
20d ago
Bristol Myers Squibb (BMY)
LinkedIn
Medium volume
83%
last
11d ago
Credit Controller
LinkedIn
Medium volume
92%
last
19d ago
Virtual Machines
LinkedIn
Medium volume
98%
last
16d ago
Programmable Logic Controller (PLC)
LinkedIn
Medium volume
92%
last
16d ago
Article
LinkedIn
Medium volume
92%
last
23d ago
Mental Health
LinkedIn
Medium volume
96%
last
19d ago
Good Manufacturing Practice (GMP)
LinkedIn
Medium volume
98%
last
25d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at Indivior

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others9 active
Directorresearching Programmable Logic Controller (PLC)
in
Leadershipresearching Career Development
in
researching Pharmaceutical
in
Directorresearching Sales Development
in
entryresearching Dreamforce
in
researching Opportunity
in
researching Credit Controller
in
Senior ICresearching Career Development
in
Engineering2 active
researching Regulatory Compliance
in
head of qa & qc, fcp
Leadershipresearching Article
in
+ 1 more in Engineering
Data1 active
Director, Product & Technology Launch Excellence
VPresearching Write Off
in
+ 1 more in Data

See everyone, not just the first 10

12 people across every department at Indivior, plus a LinkedIn profile link for each.

Primary products / business lines

LinkedIn company profile

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD tr

Top accounts researching Indivior

names withheld on the public page

These are companies whose own people brought up Indivior unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

6,459 companies · 25,813 people are researching Pharmaceutical

Indivior's own team shows 3 signals on this topic. No one outside Indivior has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Artificial Intelligence151,426 cos · 839,012 people
  • Hiring75,708 cos · 411,263 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching Indivior.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Engineering — 1 person

What's been said

public posts by Indivior's team

No public post naming Indivior has surfaced in the past year, so this is what Indivior's own team is posting about publicly — their topics, in their words.

LinkedIn

Super proud Mom moment! Wow did these years fly! Spending time in Pittsburgh was awesome for me (huge Steelers fan) and Jack is really thriving there- what a great city. An ask for my network please - if anyone is aware of relevant roles (Pittsburgh-based or remote), I would appreciate any and all insights or referrals. Thanks all.

May 2026
LinkedIn

📣I’m looking for someone who thrives in a performance driven, culture•Brings strong clinical and sales acumen•Is passionate about educating providers and staff• Can execute strategically while building trusted customer relationships• Wants to be part of a high-performing, patient-focused team!

May 2026
LinkedInGTM Planning

We didn't launch Blueprint Health Strategies Group with a post. We launched it with a client. So now that we've come up for air, here's an introduction. I founded Blueprint Health Strategies Group alongside my partners, Matthew "Matt" R Ruth and Jonathan Bloomfield , to close a gap we kept running into throughout our careers: companies with strong science and real potential, stuck between strategy and execution. Rare disease. Complex products. Markets where the standard playbook doesn't apply and access is anything but straightforward. BHSG exists to be the team that actually gets in and does the work. Commercial buildouts, market access strategy, rare disease go-to-market, expert network activation, and transaction support. We work alongside our clients' leadership, not above it. Over the last six months we've been coast to coast, in the rooms and at the tables that matter. That's what this looks like in practice: early, relationship-driven, and present when it counts. If you're navigating a commercialization challenge, a market access question, or a rare disease launch and you need people who've genuinely done it, I'd love to connect. #BlueprintHSG #RareDisease #MarketAccess #HealthcareCommercial #CommercialStrategy

May 2026
LinkedIn

Exciting progress! Congrats to team Frenelle. Completing PK/tox for FRN01 is a meaningful milestone for patients with OUD who desperately need better treatment options. The hub-and-spoke model looks like a smart way to drive capital-efficient innovation across multiple programs. Looking forward to watching this one continue to develop.

May 2026
Straight from Indivior: 4 earnings calls and filings read in full. Leadership's own words on the public record — not analyst commentary.

Strategic priorities

Earnings call; SEC filings

Customer Relationship Management (CRM); Paid Search; Cash Flow

What changed recently

Earnings call; SEC filings

Customer Relationship Management (CRM); Paid Search; Cash Flow

About this data. Indivior (indivior.com). Department attribution is 16.67%; remaining activity is grouped under Others. Updated 2026-10-03T14:00:03.490Z.

Not yet computedPer-team narrative summaries